NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER
January 28, 2025
NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous system disorders, is proud to announce the